Psychotherapy and Psychosomatics
Schmitt A.a,b· Kulzer B.a,b,c· Ehrmann D.a,b,c· Haak T.a· Hermanns N.a,b,c
Author affiliations
aResearch Institute of the Diabetes Academy Mergentheim, Diabetes Center Mergentheim, Bad Mergentheim, Germany
bGerman Center for Diabetes Research (DZD), Muenchen-Neuherberg, Germany
cDepartment for Psychology, Otto-Friedrich-University of Bamberg, Bamberg, Germany
Log in to MyKarger to check if you already have access to this content.
Buy
FullText & PDF
Unlimited re-access via MyKarger
Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Select
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Learn more
Rent/Cloud
Rent for 48h to view
Buy Cloud Access for unlimited viewing via different devices
Synchronizing in the ReadCube Cloud
Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Select
Subscribe
Access to all articles of the subscribed year(s) guaranteed for 5 years
Unlimited re-access via Subscriber Login or MyKarger
Unrestricted printing, no saving restrictions for personal use
read more
Subcription rates
Select
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
Received: April 07, 2022
Accepted: April 08, 2022
Published online: May 06, 2022
Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0
ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)
For additional information: https://www.karger.com/PPS
First-Page Preview
References
Breznoscakova D, Pallayova M. Uncovering the untold emotional toll of living with diabetes in the COVID-19 era. Psychother Psychosom. 2022:1–2. Epub ahead of print.
Schmitt A, Kulzer B, Reimer A, Herder C, Roden M, Haak T, et al. Evaluation of a stepped care approach to manage depression and diabetes distress in patients with type 1 diabetes and type 2 diabetes: results of a randomized controlled trial (ECCE HOMO Study). Psychother Psychosom. 2022 Dec;91(2):107–22.
Farooqi A, Gillies C, Sathanapally H, Abner S, Seidu S, Davies MJ, et al. A systematic review and meta-analysis to compare the prevalence of depression between people with and without type 1 and type 2 diabetes. Prim Care Diabetes. 2022 Feb;16(1):1–10.
Chireh B, Li M, D’Arcy C. Diabetes increases the risk of depression: a systematic review, meta-analysis and estimates of population attributable fractions based on Prospective Studies. Prev Med Rep. 2019 Feb 10;14:100822.
Ehrmann D, Kulzer B, Haak T, Hermanns N. Longitudinal relationship of diabetes-related distress and depressive symptoms: analysing incidence and persistence. Diabet Med. 2015 Oct;32(10):1264–71.
COVID-19 Mental Disorders Collaborators, Santomauro DF, Herrera AMM, Shadid J, Zheng P, Ashbaugh C, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021 Nov 6;398(10312):1700–12.
Chao AM, Wadden TA, Clark JM, Hayden KM, Howard MJ, Johnson KC, et al. Changes in the prevalence of symptoms of depression, loneliness, and insomnia in U.S. older adults with type 2 diabetes during the COVID-19 pandemic: the Look AHEAD Study. Diabetes Care. 2022 Jan 1;45(1):74–82.
Schlicker S, Weisel KK, Buntrock C, Berking M, Nobis S, Lehr D, et al. Do nonsuicidal severely depressed individuals with diabetes profit from internet-based guided self-help? Secondary analyses of a pragmatic randomized trial. J Diabetes Res. 2019 May 14;2019:2634094.
Hermanns N, Ehrmann D, Shapira A, Kulzer B, Schmitt A, Laffel L. Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes. Diabetologia. 2022. Epub ahead of print.
Article / Publication Details
Received: April 07, 2022
Accepted: April 08, 2022
Published online: May 06, 2022
Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0
ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)
For additional information: https://www.karger.com/PPS
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
留言 (0)